Expert Speakers

2023 Speakers

Discover which expert speakers and KOLs are presenting at the 2nd Annual mRNA-Based Therapeutics Summit Europe this January 2023. 

BIOPHARMA
ACADEMICS/ NFP
SERVICE PROVIDERS

BIOPHARMA LEADERS

Xinyue (Frank) Zhang

Manager

GeneLeap Biotech

Silvia Aiolli

Head of GRA mRNA Franchise

Sanofi

Heinrich Haas

Vice President - Ribonucleic Acid Formulation & Drug Delivery

BioNTech AG

Andreas Kuhn

Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing

BioNTech

Adam Williams

Director, mRNA Commercial Strategy & Innovation

Pfizer

Charles Jones

Senior Director, mRNA Commercial Strategy & Innovation

Pfizer

Jason DelCarpini

Jason DelCarpini

Associate Director, Quantitative Bioanalytics

Moderna

Nelson Chau

Senior Vice President - Platform

Orna Therapeutics

Dr. Alexander Gebauer

Chief Executive Officer

Secarna Pharmaceuticals

Christian Maine

Compound Development Team Lead

Replicate Bioscience

Thomas Langenickel

Chief Medical Officer

Ethris GmbH

Metin Kurtoglu

Chief Operating Officer

Cartesian Therapeutics

De-Min Zhu

President & Chief Executive Officer

Cureport

Gregory Fiore

Co-Founder & Chief Executive Officer

Exacis Biotherapeutics

Stefano Gulla

Vice President, Biology Head, Protein Therapeutics

RVAC Medicines

Daniel Tondera

Head of Biology

Pantherna Therapeutics

Michelle Lynn Hall

Associate Vice President

Lilly and Company

Michiel Lodder

Chief Executive Officer

20Med Therapeutics

Lorna Harries

Chief Scientific Officer - Research & Development Lead

Senisca

Gabriel Helmlinger

Head of Translational Pharmacology

BIORCHESTRA

Heather Mallory

Investigator

GeneLeap Biotech

Suzanne Saffie-Siebert

Chief Executive Officer & Chairwoman

SiSaf Ltd

Aviad Pato

Head of Research & Natural Killer Cells

Gamida Cell

Oliver Ernst

Chief Executive Officer

NEUWAY Pharma

Adrien Villain

Bioinformatics Scientist

Sanofi

Covadonga Paneda

Chief Development Officer

Altamira Therapeutics

Thimmaiah Chendrimada

Chief Scientific Officer & Co-Founder

Chimeron Bio

ACADEMIC & NFP LEADERS

Roy van der Meel

Assistant Professor

Eindhoven University of Technology

Camilla Foged

Professor - Vaccine Design & Delivery

University of Copenhagen

Steve Pascolo

Researcher

University Hospital Zurich

Giovanna Lollo

Associate Professor

Universite Claude Bernard Lyon

Dan Murphy

Scientist

Nanocell Therapeutics

Nagy Habib

Head of Surgery Hammersmith Campus

Imperial College London

Khalid Khabar

Director of Molecular BioMedicine Program

King Faisal Specialist Hospital & Research Centre

Cees J.M. van Rijn

Professor of Nanotechnology & Microfluidics

University of Amsterdam

Harris Makatsoris

Professor of Manufacturing Systems

King’s College London

Koen Raemdonck

Professor

Ghent University

Zoltán Kis

Lecturer

University of Sheffield

Valeria Chiono

Full Professor

Politecnico di Torino

Matthias Gaestel

Professor

Hannover Medical University

Anna Särnefält

Chemistry, Manufacturing & Controls Lead

CEPI

Paolo Lusso

Chief of Viral Pathogenesis Section

National Institute of Allergy & Infectious Diseases

Cristina Bruno

Program Manager - mRNA Technology Transfer

World Health Organization

LEADING SOLUTION PARTNERS

Martha Perez

Marketing Director and Product Manager for Nunchuck

Unchained Labs

Ben Peacock

Head of Research

NanoFCM

Ann Gidner

Head of Research, Chief Executive Officer

Ziccum

Dave Sokolowski

Global Workflow Manager Acid Therapeutics

Cytiva

Tomas Kostelec

Technology and Business Development Manager

Sartorius BIA Separations

Ioana Panait

Lead Research Analyst

Beacon Targeted Therapies

Phil Challis

VP, Product Development

eTheRNA Immunotherapies

May Guo

Vice President, Nucleic Acids

Arranta Bio

Khaled Yamout

Senior Director, Manufacturing and Quality Control

TriLink BioTechnologies

Eleni Samaridou

Principal Scientist, Early Formulation Screening Service, Life Science Services

Merck KGaA

Nuria Gomez Santos

Head of Process & Analytical Development

Catalent Inc.

Martin Rabel

Senior Field Application

Precision NanoSytems

Nargisse El Hajjami PhD Eng

Process Technology Manager for mRNA & Emerging Modalities

Sartorius

Matthias Lübbert

Principal Process Engineer

KNAUER

Dr. Leslie Friedmann

Product Manager, Automated Electrophoresis

Agilent

Darwin Asa

Global Market Development Manager, Nucleic Acid Therapeutics,

Thermo Fisher

Christof Trabszo

Head of Quality Control, mRNA CDMO, Life Science Services

Merck KGaA

EVENT GUIDE